Phosphagenics is a Melbourne-based, biotechnology company founded in 1999 that is focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products. Phosphagenics’ core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms. Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR – Level 1 program has been established with the Bank of New York (PPGNY) for US investors to trade in Phosphagenics' stock on the ‘over-the-counter’ market. Phosphagenics was formerly known as Vital Health Capital Limited